Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in inflammatory bowel disease: a survey from the Middle East.
Gaurav Bhaskar NigamKelly ChattenAla ShararaTalal Al-TaweelOthman AlharbiHussein ElaminSameer Al AwadhiVito AnneseJimmy K LimdiPublished in: Therapeutic advances in gastroenterology (2024)
Most gastroenterologists use TDM for LOR, with cost, time lag and insurance reimbursement being significant barriers. Addressing these barriers would increase the judicious use of reactive and proactive TDM to optimize anti-TNF therapy in IBD.